Clinical Trial: A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421232) titled 'A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia' on Feb. 12.

Brief Summary: The purpose of this study is to compare the effectiveness, safety of SYH2053 in Participants with primary hypercholesterolemia or mixed dyslipidemia.

A total of 156 Participants were actually enrolled

Study Start Date: Dec. 03, 2024

Study Type: INTERVENTIONAL

Condition: Hypercholesterolemia and Mixed Hyperlipidemia

Intervention: DRUG: SYH2053/placebo injection

Participants receive SYH2053/placebo injection by subcutaneous administration.

DRUG: Inclisiran (Leq...